406 related articles for article (PubMed ID: 21475304)
1. Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy.
Vara D; Salazar M; Olea-Herrero N; Guzmán M; Velasco G; Díaz-Laviada I
Cell Death Differ; 2011 Jul; 18(7):1099-111. PubMed ID: 21475304
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells.
Salazar M; Carracedo A; Salanueva IJ; Hernández-Tiedra S; Lorente M; Egia A; Vázquez P; Blázquez C; Torres S; García S; Nowak J; Fimia GM; Piacentini M; Cecconi F; Pandolfi PP; González-Feria L; Iovanna JL; Guzmán M; Boya P; Velasco G
J Clin Invest; 2009 May; 119(5):1359-72. PubMed ID: 19425170
[TBL] [Abstract][Full Text] [Related]
3. The pseudokinase tribbles homologue-3 plays a crucial role in cannabinoid anticancer action.
Salazar M; Lorente M; García-Taboada E; Hernández-Tiedra S; Davila D; Francis SE; Guzmán M; Kiss-Toth E; Velasco G
Biochim Biophys Acta; 2013 Oct; 1831(10):1573-8. PubMed ID: 23567453
[TBL] [Abstract][Full Text] [Related]
4. Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma.
Vara D; Morell C; Rodríguez-Henche N; Diaz-Laviada I
Cell Death Dis; 2013 May; 4(5):e618. PubMed ID: 23640460
[TBL] [Abstract][Full Text] [Related]
5. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma.
Shimizu S; Takehara T; Hikita H; Kodama T; Tsunematsu H; Miyagi T; Hosui A; Ishida H; Tatsumi T; Kanto T; Hiramatsu N; Fujita N; Yoshimori T; Hayashi N
Int J Cancer; 2012 Aug; 131(3):548-57. PubMed ID: 21858812
[TBL] [Abstract][Full Text] [Related]
7. Nilotinib induces autophagy in hepatocellular carcinoma through AMPK activation.
Yu HC; Lin CS; Tai WT; Liu CY; Shiau CW; Chen KF
J Biol Chem; 2013 Jun; 288(25):18249-59. PubMed ID: 23677989
[TBL] [Abstract][Full Text] [Related]
8. Suppression of AKT anti-apoptotic signaling by a novel drug candidate results in growth arrest and apoptosis of hepatocellular carcinoma cells.
Cuconati A; Mills C; Goddard C; Zhang X; Yu W; Guo H; Xu X; Block TM
PLoS One; 2013; 8(1):e54595. PubMed ID: 23355882
[TBL] [Abstract][Full Text] [Related]
9. Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.
Wang C; Gao D; Guo K; Kang X; Jiang K; Sun C; Li Y; Sun L; Shu H; Jin G; Sun H; Wu W; Liu Y
BMC Cancer; 2012 May; 12():166. PubMed ID: 22559167
[TBL] [Abstract][Full Text] [Related]
10. β-Thujaplicin induces autophagic cell death, apoptosis, and cell cycle arrest through ROS-mediated Akt and p38/ERK MAPK signaling in human hepatocellular carcinoma.
Zhang G; He J; Ye X; Zhu J; Hu X; Shen M; Ma Y; Mao Z; Song H; Chen F
Cell Death Dis; 2019 Mar; 10(4):255. PubMed ID: 30874538
[TBL] [Abstract][Full Text] [Related]
11. CB2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signaling.
Palazuelos J; Ortega Z; Díaz-Alonso J; Guzmán M; Galve-Roperh I
J Biol Chem; 2012 Jan; 287(2):1198-209. PubMed ID: 22102284
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
[TBL] [Abstract][Full Text] [Related]
13. PSPH induces cell autophagy and promotes cell proliferation and invasion in the hepatocellular carcinoma cell line Huh7 via the AMPK/mTOR/ULK1 signaling pathway.
Zhang J; Wang E; Zhang L; Zhou B
Cell Biol Int; 2021 Feb; 45(2):305-319. PubMed ID: 33079432
[TBL] [Abstract][Full Text] [Related]
14. The mTOR inhibition in concurrence with ERK1/2 activation is involved in excessive autophagy induced by glycyrrhizin in hepatocellular carcinoma.
Zhang X; Yang H; Yue S; He G; Qu S; Zhang Z; Ma B; Ding R; Peng W; Zhang H; Yang Z; Dou K; Tao K; Li X
Cancer Med; 2017 Aug; 6(8):1941-1951. PubMed ID: 28675698
[TBL] [Abstract][Full Text] [Related]
15. AZD8055 induces cell death associated with autophagy and activation of AMPK in hepatocellular carcinoma.
Hu M; Huang H; Zhao R; Li P; Li M; Miao H; Chen N; Chen M
Oncol Rep; 2014 Feb; 31(2):649-56. PubMed ID: 24297300
[TBL] [Abstract][Full Text] [Related]
16. Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo.
Shao H; Gao C; Tang H; Zhang H; Roberts LR; Hylander BL; Repasky EA; Ma WW; Qiu J; Adjei AA; Dy GK; Yu C
J Hepatol; 2012 Jan; 56(1):176-83. PubMed ID: 21835141
[TBL] [Abstract][Full Text] [Related]
17. mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinoma.
Thomas HE; Mercer CA; Carnevalli LS; Park J; Andersen JB; Conner EA; Tanaka K; Matsutani T; Iwanami A; Aronow BJ; Manway L; Maira SM; Thorgeirsson SS; Mischel PS; Thomas G; Kozma SC
Sci Transl Med; 2012 Jun; 4(139):139ra84. PubMed ID: 22539746
[TBL] [Abstract][Full Text] [Related]
18. Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.
Lin XM; Hu L; Gu J; Wang RY; Li L; Tang J; Zhang BH; Yan XZ; Zhu YJ; Hu CL; Zhou WP; Li S; Liu JF; Gonzalez FJ; Wu MC; Wang HY; Chen L
Gastroenterology; 2017 Apr; 152(5):1187-1202. PubMed ID: 28065789
[TBL] [Abstract][Full Text] [Related]
19. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.
Calvisi DF; Wang C; Ho C; Ladu S; Lee SA; Mattu S; Destefanis G; Delogu S; Zimmermann A; Ericsson J; Brozzetti S; Staniscia T; Chen X; Dombrowski F; Evert M
Gastroenterology; 2011 Mar; 140(3):1071-83. PubMed ID: 21147110
[TBL] [Abstract][Full Text] [Related]
20. CC-223 blocks mTORC1/C2 activation and inhibits human hepatocellular carcinoma cells in vitro and in vivo.
Xie Z; Wang J; Liu M; Chen D; Qiu C; Sun K
PLoS One; 2017; 12(3):e0173252. PubMed ID: 28334043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]